Full Text View
Tabular View
No Study Results Posted
Related Studies
An Open-label Study of KW-3357 (3357-004)
This study has been completed.
Study NCT01384903   Information provided by Kyowa Hakko Kirin Company, Limited

First Received on June 27, 2011.   Last Updated on June 4, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Disseminated Intravascular Coagulation
More general conditions related to this trial
Blood Coagulation Disorders
Hematologic Diseases
Hemorrhagic Disorders
Thrombophilia
Interventions listed in this trial
KW-3357
Plasma-derived antithrombin
Additional drug interventions recognized in this trial
Antithrombin III
Antithrombin Proteins
Antithrombins
More general drug interventions related to this trial
Anticoagulants
Enzyme Inhibitors
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Serine Proteinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Kyowa Hakko Kirin Company, Limited


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services